Abbott is a global healthcare leader that helps people live more fully at all stages of life. Our portfolio of life-changing technologies spans the spectrum of healthcare, with leading businesses and products in diagnostics, medical devices, nutritionals and branded generic medicines. Our 103,000 colleagues serve people in more than 160 countries.


Headquartered in Basel, Switzerland, Roche is a leader in research-focused healthcare with combined strengths in pharmaceuticals and diagnostics. Roche is the world’s largest biotech company, with truly differentiated medicines in oncology, immunology, infectious diseases, ophthalmology and neuroscience. Roche is also the world leader in in vitro diagnostics and tissue-based cancer diagnostics, and a frontrunner in diabetes management.


Beckman Coulter Diagnostics develops clinical diagnostic products that help advance and optimize the clinical laboratory. Based in Brea, Calif., Beckman Coulter’s instruments, systems and tests help streamline processes to enhance efficiency, reduce costs and speed the delivery of results. For more than 80 years, Beckman Coulter has been a global leader devoted to providing solutions to laboratories of all sizes—offering a broad portfolio of chemistry, immunoassay, hematology, urinalysis, automation and information systems. Beckman Coulter is, and always has been, singularly devoted to moving science, innovation and the lab forward.


Biogenix had an inception in April 2020, and has been uniquely positioned to drive holistic testing capabilities, to develop and deploy holistic and scalable healthcare diagnostic solutions for UAE residents. We have been known for strict adherence to national and international standards and benchmarks like DOH standards and ISO15189. We designed, built and mobilized the UAE’s first COVID-19 dedicated detection lab within 15 days. In this state-of-the-art laboratories we process tens of thousands of RT-PCR tests per day and is the first in the world of this scale to be operational outside China. The lab showcases the commitment of G42 to support the UAE government to combat the COVID-19 pandemic.

Biogenix Labs, as a part of G42 Healthcare, have an exciting program of activity to support the health of future generations. We partner extensively with leading international players who complement our ecosystem and support delivery of our mandates. We have the widest test menu and panels in the disciplines of Molecular Diagnostics, clinical biochemistry, clinical immunology, metabolic testing, hormonal analysis, hematology including Flow Cytometry, Immunophenotying, Cytogenetics, Histopathology and Cytology. Biogenix has internationally accepted external and internal quality assurance programs in place.


G42 is an artificial intelligence (AI) and cloud computing company based in Abu Dhabi. We build and manage significant cloud computing infrastructure, perform fundamental and applied AI research, and deploy AI-centric solutions across a range of industries:

• Smart City
• Healthcare
• Oil and gas
• Financial services
• Utilities
• Aviation
• and more...

G42 was created with AI research and Cloud computing at the core. This way we can develop the most progressive solutions to problems in every sector and of every scale. As we execute our mission, we are poised to lead the evolution of AI from its current narrow scope towards the age of Artificial General Intelligence to a much wider role in which AI mirrors human intelligence and consciousness to unlock new avenues for growth and efficiency.


Operational efficiency is at the core of our business and Pure Health is committed to delivering efficient healthcare solutions to a booming industry. The UAE is leading the way for hospitals to counter business challenges by leveraging a host of innovative, integrated, and focused solutions designed to deliver the highest level of quality and drive customer satisfaction.


Seegene, Inc. is an in-vitro diagnostics (IVD) company that has been turning concepts into products through its pioneering R&D activities. Founded in Seoul in 2000 and with subsidiaries in Rockville, Maryland, USA and Eschborn, Germany, Seegene has developed innovative technology platforms including ACP™ (Annealing Control Primer), DPO™ (Dual Priming Oligonucleotide), and READ™ (Real Amplicon Detection).

With these cutting-edge molecular diagnostic (MoDx) technologies applied to diagnostic kits and other tools, Seegene has enhanced the sensitivity and specificity of PCR (polymerase chain reaction) to unprecedented levels. Seegene provides multiplex PCR products which target and detect genes of multiple pathogens simultaneously, saving testing time and cost. Seegene will continue to set new standards in MoDx and provide new, cost effective innovations.


Siemens Healthineers enables healthcare providers worldwide to increase value by empowering them on their journey towards expanding precision medicine, transforming care delivery, improving patient experience and digitalizing healthcare. A leader in medical technology, Siemens Healthineers is constantly innovating its portfolio of products and services in its core areas of diagnostic and therapeutic imaging and in laboratory diagnostics and molecular medicine. Siemens Healthineers is also actively developing its digital health services and enterprise services.


We are Over 250 laboratories and 150 imaging units and with abroad
catalogue of more than 6,500 diagnostic tests, Unilabs is a leading European
provider of clinical laboratory testing and medical diagnostic imaging
services. Headquartered in Geneva, Switzerland the Unilabs Group serves private
and public healthcare providers, local governments, pharmaceutical companies
and the general public. The company employs more than 12,700 people worldwide,
successfully operates laboratory and medical diagnostic imaging facilities in
17 countries. 


As a biotechnology company, Vazyme is committed to research and development both in technology and products focusing on functional proteins, such as enzymes, antigens, antibodies, and polymer organic materials. Relying on self-established critical generic technology platform, Vazyme successively marched into various business area: biological research, in vitro diagnosis (IVD), bio-pharmaceutical and so on. Moreover, our company is regarded as one of the few domestic R&D innovative enterprises that have capabilities of both independent and controllable upstream technology development and terminal product production. With “biochip” made in China, Vazyme is ready to provide source power for biotechnology industry.


BD is a global medical technology company that is advancing the world of health by improving medical discovery, diagnostics and the delivery of care. BD leads in patient and health care worker safety and the technologies that enable medical research and clinical laboratories. The company provides innovative solutions that help advance medical research and genomics, enhance the diagnosis of infectious disease and cancer, improve medication management, promote infection prevention, equip surgical and interventional procedures and support the management of diabetes.The company partners with organizations around the world to address some of the most challenging global health issues. BD has more than 65,000 associates across 50 countries who work in close collaboration with customers and partners to help enhance outcomes, lower health care delivery costs, increase efficiencies, improve health care safety and expand access to health.


EUROIMMUN is an international provider of medical laboratory products for autoimmune, infection, allergy and molecular genetic diagnostics. The company’s portfolio encompasses indirect immunofluorescence, ELISA, immunoblot, radioimmunoassay, ChLIA and molecular genetic test systems and spans over a thousand diagnostic parameters. State-of-the-art instruments and software provide efficient automation of analyses, increasing productivity and reliability in routine diagnostics. EUROIMMUN scientists participate in many international research projects, contributing to cutting-edge advances in laboratory diagnostics. Pioneering developments include BIOCHIP technology, designer antigens, recombinant-cell IFT and computer-aided immunofluorescence microscopy. A renowned reference laboratory and a quality assurance programme are part of EUROIMMUN’s expert technical service.


PerkinElmer enables scientists, researchers and clinicians to address their most critical challenges across science and healthcare. With a mission focused on innovating for a healthier world, we deliver unique solutions to serve the diagnostics, life sciences, food and applied markets. We strategically partner with customers to enable earlier and more accurate insights supported by deep market knowledge and technical expertise. Our dedicated team of about 14,000 employees worldwide is passionate about helping customers work to create healthier families, improve the quality of life, and sustain the well-being and longevity of people globally.


AIM FOR PERFECTION IS THE ONLY WAY TO REACH IT. We are an Italian leading laboratory equipment manufacturer that has been producing laboratory products for medical technology since 1979.We have been successful year after year by manufacturing medical laboratory equipment constantly improved through a hard work. We like what we do and we do it well. This is possible because we want to offer our customers not only high quality medical lab equipment, but experience, professionalism and the broadest guarantees, too.


This year, HORIBA Medical will show its hematology high-end Solution : Yumizen H2500, Yumizen SPS and Yumizen P8000, compatible with the HELO* Solution (HORIBA Evolutive Laboratory Organisation). You will also find Yumizen H550 analyzer which meets the needs and features of mid-size laboratories.

On this occasion, we will present our different configurations of laboratory organization as well as our comprehensive range of coagulation instruments.


Life Diagnostics has been established in 1998 at the heart of Abu Dhabi, United Arab Emirates as a fully-fledged diagnostic center that provides a wide range of laboratory and radiology services through adopting innovative technologies to deliver exceptional diagnostic services.

Our management is driven by the passion to provide a unique diagnostic experience that helps healthcare professionals to diagnose, treat, monitor and prevent diseases. We provide a broad range of routine, specialized and high complexity diagnostics services. Life Diagnostics adopting innovative technologies and instruments for clinical testing and imaging to deliver exceptional diagnostic services. Life Dx also focuses on developing a unique and wide scope of service by investing in laboratory and imaging expertise. We established strong and open partnerships with a world-class laboratory to expand our offerings to our clients.


LumiraDx was founded in 2014 by a group of entrepreneurs with a successful track record in building and scaling diagnostics and health IT businesses. These included Medisense, Inverness Medical and Alere. Having worked together for more than a decade, this team brings significant expertise in:Developing, manufacturing and commercializing industry-leading Point of Care (POC) diagnostic platformsUsing cloud-based platforms to integrate health system networks and transfer patient dataUsing data to develop supported self-care plans to improve individuals' health and system-wide outcomes


Founded in 1991, Mindray is one of the leading global providers of medical devices and solutions. Firmly committed to our mission of “advance medical technologies to make healthcare more accessible”, we are dedicated to innovation in the fields of Patient Monitoring & Life Support, In-Vitro Diagnostics, and Medical Imaging System.Mindray possesses a sound global R&D, marketing and service network. Inspired by the needs of our customers, we adopt advanced technologies and transform them into accessible innovation, bringing healthcare within reach. While improving the quality of care, we help reducing its cost, making it more accessible to a larger part of humanity.Today, Mindray’s products and services can be found in healthcare facilities in over 190 countries and regions. In China, Mindray’s products and solutions can be found in nearly 110,000 medical institutions and 99% of Class A tertiary hospitals.


National Reference Laboratory (NRL) is focused on increasing the quality, spectrum, coverage and overall efficiency of laboratory testing in the UAE and the region. As a Mubadala Healthcare provider, it implements international best-practice reference-laboratory processes and aims to set the benchmark for quality standards in the region.NRL offers a comprehensive menu of tests, expanded in response to the needs of the region and providing a complete solution for all clinical testing needs in an efficient and high-quality environment. Of the 7.5+ million tests performed annually, 98% are done in house, allowing for greater quality control and reducing both turnaround time and logistics-related costs compared with other referral laboratories.


A Global Leader of In Vitro Diagnostics for over 80 years, Our purpose is simple: to improve and save lives with diagnostics. We do that by reimagining what’s possible. It’s what defines us. It’s made us a trusted partner of hospitals, hospital networks, blood banks, and labs around the world. And today it’s empowering us to advise our customers as they prepare for what’s next.


Randox is committed to developing revolutionary diagnostics, improving health globally and saving lives. Our product range includes clinical chemistry and immunoassay analysers and high quality reagents. Comprising third party controls, inter-laboratory data management and the world’s largest global EQA scheme, the Randox Quality Control package is the most comprehensive available. Biochip Array Technology is a unique multiplexing method offering clinical, research and molecular panels. Randox Toxicology offer solutions for fast and accurate drug detection within forensic and clinical toxicology. Evidence Series immunoanalysers have been designed to utilise Biochip Array Technology, ensuring financial, labour and time savings for end users..


Sansure Biotech Inc. was founded in 2008 as a dedicated company developing and manufacturing a complete product line for molecular laboratories, ranging from upstream nucleic acid extraction kits and full automation to downstream real time PCR diagnostic & research kits and fluorescence systems. Based on innovative R&D center in Changsha, China, Sansure understands its capability and social responsibility to offer molecular diagnostic products consistent in quality, accurate and reliable in test results, easy to use and accessible to laboratories of all levels despite their variety in lab environment. Sansure is gradually winning its reputation all over the world and exerting growing influence on popularizing qPCR technologies towards what they are supposed to be as affordable and accessible human health care means.

Sansure has cooperated with more than 2000 hospitals and laboratories contributing to daily consumption of over 100,000 tests.Nine out of the ten top hospitals specialized in infectious diseases are Sansure loyal clients. Globally, Sansure innovative technologies now have been introduced into more than 140 countries and regions including Europe, Middle East, Asia, Africa and South and Central America where Sansure has received recognition.


Created in 1945 as a pharmaceutical company, Diagnostica Stago is now a world leader in the In-Vitro Diagnostics industry. Global, privately-owned and independent, Stago is fully dedicated to the exploration of Thrombosis and Haemostasis. Day in and day out, Stago is committed to enhancing the quality of healthcare by offering laboratories advanced testing systems and superior services, the fruit of our expertise and know-how in Haemostasis (reagents, instruments and disposables).

Distributed in over 110 countries through a network of subsidiaries and exclusive distributors, we are in a position to guarantee our customers superior service and a product portfolio meeting the demands of global healthcare systems. Today, 90% of our production, developed and made in France, is exported. Specialising in the field of coagulation for over 60 years, Stago has acquired solid industrial experience (R&D, standardisation and production) in the field of In Vitro Diagnostics and lasting recognition from the scientific community.

The field of biomedical science is constantly evolving and expanding; new discoveries are moving medicine increasingly towards individual treatments that require diagnostic markers and ever more precise exploratory tools. These are our challenges of tomorrow. Stago, relying on strong human and technological potential, will still have much to contribute in the years to come.


Thermo Fisher Scientific Inc. (NYSE: TMO) is the world leader in serving science, with revenues of more than $24 billion and approximately 70,000 employees globally. Our mission is to enable our customers to make the world healthier, cleaner and safer. We help our customers accelerate life sciences research, solve complex analytical challenges, improve patient diagnostics, deliver medicines to market and increase laboratory productivity. Through our premier brands – Thermo Scientific, Applied Biosystems, Invitrogen, Fisher Scientific and Unity Lab Services – we offer an unmatched combination of innovative technologies, purchasing convenience and comprehensive services. For more information, please visit


BioPerfectus, a public listed company at Shanghai Stock Exchange (SSE:688399), is one of the leading molecular diagnostic solution manufacturers in global in-vitro diagnostics market since 2010.  With headquarter located in Taizhou, branch offices sited in Shanghai, Xi’an and Beijing, Bioperfectus is pioneering in molecular diagnostics market with our products ranging from real time PCR kits, nucleic acid extraction systems, rapid tests and automation laboratory devices etc...  

Since the inception of International Sales and Marketing Division in June, 2020, under the authorization of international renowned public health organizations and institutions, our products have been distributing in over 50 countries all over the world and about to come to cover more countries in the near future.  Young and passionate, Bioperfectus people are working steadily and firmly to achieve our dream to create a healthier future for our next generations.


Bio-Rad is a global leader in developing, manufacturing, and marketing a broad range of innovative products for the life science research and clinical diagnostic markets. With a focus on quality and customer service for over 65 years, our products advance the discovery process and improve healthcare. Our customers include university and research institutions, hospitals, public health and commercial laboratories, biotechnology, pharmaceutical, as well as applied laboratories that include food safety and environmental quality.

Live in-person:
21 - 24 June 2021

23 May - 22 July 2021